Latin America Infection Control Market Size and Growth rate:
Latin America Infection Control Market was valued at around USD 1,604.4 million in 2018 and it is expected to reach USD 2,592.2 million by 2025, growing at a CAGR of approximately 7.20% over the forecast period.
According to Research Cosmos Global Infection Control Market expected to reach 30,002.1 Million USD by 2025, growing with a CAGR of 6.77 %.
The infection control market is largely driven by the high incidence of SSIs and hospital-acquired infections (HAIs), the increasing number of surgical procedures, the rapidly increasing pharmaceutical industry, and the growing need for food sterilization in life science and medical equipment industry. With the growing infection outbreaks and growing experience in the healthcare sector, infection control requirements are achieving greater significance.
Growth Drivers, Challenges, and Opportunities:
The increasing number of government initiatives to ensure a large degree infection prevention is presumed to be a meaningful driver of the Latin American market. The government organizations are frequently involved in distributing guidelines in order to promote awareness pertaining to efficient prevention measures, which is anticipated to contribute to the market growth throughout the forecast period.
The World Health Organization has published guidelines for the prevention and control of pandemic and epidemic-prone acute respiratory diseases in healthcare. The guideline ranges from usual precautions like personal protective equipment, hand hygiene, to guidelines for disinfection and sterilization. Appropriately to the statistics issued by WHO, Acute Respiratory Diseases (ARDs) is one of the major causes of high mortality rates globally. Around 4.0 million deaths occur every year due to ARDs. The aforementioned statistics represent the high need for stringent prevention and control of disorders.
Diseases such as pneumonia and infections such as bloodstream, urinary tract, surgical site, MRSA constitute a majority of the overall hospital-acquired infections. Other major hospital-acquired infections include catheter-associated urinary tract infections, ventilator-associated pneumonia, and catheter-related bloodstreams. HAI is believed to be one of the major concerns, that affects patient recovery, thereby, creating a major impact on mortality grows globally.
Appropriately to a practical guide published by the WHO on the prevention of HAI, the increase in hospitalization duration with surgical infections was found to be approximately eight days. These extended stays are predicted to be a significant contributor to the overall costs, incurred during the hospitalization period, thus, raising the clinical urgency for the adoption of infection control measures.
It is presumed that prolonged hospital stay is also not economical for the hospitals and healthcare payers as a consequence of excessive usage of resources to treat the acquired infection. These further costs are majorly generated through improved usage of drugs, additional diagnostic studies, laboratory equipment, creating a resource allocation imbalance.
Latin America Infection Control Market Segmentation Overview:
Based on services and products, the endoscope reprocessing products segment is expected to grow at the highest CAGR during the forecast period. This can be connected to the growing importance of therapeutic endoscopy procedures and diagnostic advanced technologies, reasonably stable reimbursement scenario, and concerns regarding patient-to-patient cross-infection caused due to improper endoscope reprocessing.
Based on the formulation, the disinfectant sprinkles segment is expected to show the quickest growth during the forecast period. Disinfectant sprays used in the fogging of hospital rooms and operation theaters are increasingly being adopted due to its ease of handling and effectiveness in serving the purpose of room and surface disinfection.
Based on the type of cleaning and disinfection equipment, the UV-ray disinfectors segment is expected to increase at the highest CAGR during the forecast period. This is attributed to the growing adoption of UV-ray disinfectors owning to its advantages like chemical-free, environmental friendliness, and an effective method of disinfection. UV rays have been commercially utilized for multiple years in the pharmaceutical,
Geographical Insights of Latin America Infection Control Market
The Latin America infection control market is expected to grow at the second largest CAGR during the forecast period. Emerging economies in the region such as Guatemala, Chile, Peru, and Costa Rica along with the developed markets of Brazil and Mexico are offering high growth opportunities for market players in this regional market.
Infection Control is one of the quickly growing markets in Latin America nations such as Argentina, Brazil, and Mexico due to high expenditures concerned with preventing healthcare-associated infection and aseptic technique is a major component of all invasive surgical process. Infection prevention and control play a crucial role in hospitals and clinics, as it prevents the spread of infections in healthcare settings.
Prominent Companies Dominating the Market analyzed in this report are:
- Nordion Inc.
- Johnson and Johnson
- CISA Group
- Steris Corporation
- Belimed AG
- Getinge Group
- Kimberly-Clark Corporation
- Cantel Medical Corporation
- Synergy Health plc.
- STERIS plc
- Advanced Sterilization Products
- 3M Company
- Belimed AG
- MMM Group
- Matachana Group
- Sotera Health LLC
- Ecolab, Inc.
- Metrex Research Corporation
- Reckitt Benckiser Group Plc.
- Miele Group
- Pal International